All News #Library
Others
Outlook Therapeutics Receives FDA Agreement for 3 Special Protocol Assessments
03 Dec 2019 //
GLOBE NEWWIRE
Outlook Therapeutics closes enrolment in Phase III wet AMD study
21 Aug 2019 //
CLINICALTRIAL SARENA

Market Place
Sourcing Support